NCT06830525

Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 40 (actual)
• Sponsor: Luis Fernandez Luque · Industry
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The goal of this observational study is to learn how to make growth hormone treatment more personalized for children. The main questions it aims to answer are: * How can information about treatment adherence and patient experiences help improve care? * What insights can help doctors create treatment plans that are more tailored to each child? The study will include 40 families of children who are using a connected injector device for their growth hormone treatment. These devices track how often the treatment is taken, and families will also share their experiences through surveys. The information will be used to develop a new tool, similar to tools used in diabetes care, to help doctors create better, personalized treatment plans for children with growth hormone needs.

Conditions

• Growth Hormone Deficiency (GHD)

Interventions

Type	Name	Description
COMBINATION_PRODUCT	ACDP® and growth hormone treatment	A cohort of 40 families of children undergoing growth hormone treatment using a connected injector devices that quantifies treatment adherence will be recruited via the ACDP®, to capture additional data that combine Patient Reported Outcomes and Adherence Data.

Timeline

• Start date: 2025-05-19
• Primary completion: 2025-11-12
• Completion: 2025-11-12
• First posted: 2025-02-17
• Last updated: 2025-12-01

Locations

1 site across 1 country: Spain